Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Stirling

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Medical Bulletin|May 22, 2001
Future treatments of allergic diseases and asthmaR G Stirling, K F Chung
Molecular and Cellular Endocrinology|March 26, 1990
A high concentration of dopamine preferentially permitted release of newly synthesized prolactinR G Stirling, S H Shin
The European Respiratory Journal|April 9, 2001
New immunological approaches and cytokine targets in asthma and allergyR G Stirling, K F Chung
American Journal of Respiratory and Critical Care Medicine|November 13, 2001
Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthmaR G Stirling, E L van Rensen, P J Barnes, et al.
Respiratory Medicine|March 21, 2003
Regulation of protease-activated receptor-1 in mononuclear cells by neutrophil proteasesN Roche, R G Stirling, S Lim, et al.
Thorax|April 30, 2004
Failure of sputum eosinophilia after eotaxin inhalation in asthmaD Bumbacea, J Scheerens, B S Mann, et al.
Endocrinologia Experimentalis|March 1, 1990
Ascorbic acid potentiates the inhibitory effect of dopamine on prolactin release: a putative supplementary agent for PIFS H Shin, R G Stirling, S Hanna, et al.
The European Respiratory Journal|June 29, 2004
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophagesA Koch, M Giembycz, R G Stirling, et al.
Thorax|April 9, 1999
Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy GroupR G Stirling, S A Kharitonov, D Campbell, et al.
Thorax|November 20, 2001
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthmaE L van Rensen, R G Stirling, J Scheerens, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Medical Bulletin|May 22, 2001
Future treatments of allergic diseases and asthmaR G Stirling, K F Chung
Molecular and Cellular Endocrinology|March 26, 1990
A high concentration of dopamine preferentially permitted release of newly synthesized prolactinR G Stirling, S H Shin
The European Respiratory Journal|April 9, 2001
New immunological approaches and cytokine targets in asthma and allergyR G Stirling, K F Chung
American Journal of Respiratory and Critical Care Medicine|November 13, 2001
Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthmaR G Stirling, E L van Rensen, P J Barnes, et al.
Respiratory Medicine|March 21, 2003
Regulation of protease-activated receptor-1 in mononuclear cells by neutrophil proteasesN Roche, R G Stirling, S Lim, et al.
Thorax|April 30, 2004
Failure of sputum eosinophilia after eotaxin inhalation in asthmaD Bumbacea, J Scheerens, B S Mann, et al.
Endocrinologia Experimentalis|March 1, 1990
Ascorbic acid potentiates the inhibitory effect of dopamine on prolactin release: a putative supplementary agent for PIFS H Shin, R G Stirling, S Hanna, et al.
The European Respiratory Journal|June 29, 2004
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophagesA Koch, M Giembycz, R G Stirling, et al.
Thorax|April 9, 1999
Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy GroupR G Stirling, S A Kharitonov, D Campbell, et al.
Thorax|November 20, 2001
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthmaE L van Rensen, R G Stirling, J Scheerens, et al.
Pageof 2